Investor deep dive
AIM billionaire Clinigen is still growing at a rate of knots
Clinigen Group says acquisitions fueling expected profit growth in its trading update
Clinigen Group PLC (LON:CLIN) Head of Investor Relations Matthew Parrish tells Proactive Investors the company's recent trading update indicates that profits at the pharma services company are expected to have soared by more than a third when it reports its full-year results in September.
Gross profits were up 30%, while revenues increased by 19%, and Parrish says this significant growth was driven by M&A with the firm having closed two of its largest ever acquisitions last year.
Quick facts: Clinigen Group PLC